{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:34:33Z","timestamp":1790260473879,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40971"],"award-info":[{"award-number":["2023JJ40971"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30965"],"award-info":[{"award-number":["2023JJ30965"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec014\">\n<jats:title>Background<\/jats:title>\n<jats:p>The upper lobe is the most common site of primary lung cancer, however, very few reports focus on its prognosis. This study aims to identify prognostic factors of lung cancer in the upper lobe, as well as to establish an effective nomogram for individualized overall survival (OS) prediction.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec015\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Patients diagnosed with lung cancer were collected from the Surveillance, Epidemiology, and End Results Program (SEER) database for the period of 2010\u20132017,as recorder in the 2021 SEER database release. The demographic characteristics and OS differed in the primary sites of the upper, middle and lower lobes were drawn. The primary upper lobe lung cancer patients were further stratified by the risk indicators including Mets at DX-bone, stage, histology, grade and sex; and their OS differences in stratification were compared by the Kaplan-Meier method and the Log-Rank test. The univariate and the multivariate Cox regression were employed to determine the independent prognostic factors for the primary upper lobe lung cancer and to build a nomogram model for its OS prediction.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec016\">\n<jats:title>Results<\/jats:title>\n<jats:p>Depending on the different primary sites of lung cancer occurrence, all the collected patients were divided into three groups of the upper lobe (30295 individuals), the middle lobe (2801 individuals) and the lower lobe (16757 individuals), where the upper lobe group gained our attention with the largest population and an overwhelmingly low OS compared to the middle lobe group (<jats:italic>P &lt;0.0001<\/jats:italic>). With the results of the univariate and multivariate Cox regression model analyses, age, sex, grade, histology type, stage, regional lymph nodes removed, bone metastasis and liver metastasis were selected as the prognostic factors and a prediction nomogram model was built. The calibration curves showed no significant bias from the reference line and the concordance index between the survival nomogram prediction and the actual outcome for 2-year and 3-year OS was 0.761 (95% CI, 0.757\u20130.765). The time-dependent receiver operating characteristic curves showed that the areas under curve for 2-year and 3-year OS were 0.840 and 0.836, respectively.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec017\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>A novel nomogram was established which achieved good performance in predicting the probability of OS in the primary upper lobe lung cancer, indicating its potential value in individualized prediction of the clinical outcome in these patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0321955","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T17:40:08Z","timestamp":1745948408000},"page":"e0321955","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of a nomogram for overall survival prediction in primary upper lobe lung cancer patients: A SEER population-based analysis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2298-0240","authenticated-orcid":true,"given":"Wenze","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhuo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1920-9096","authenticated-orcid":true,"given":"Bin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"12","key":"pone.0321955.ref001","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study","volume":"5","author":"C Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"issue":"7834","key":"pone.0321955.ref002","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/d41586-020-03152-0","article-title":"Lung cancer","volume":"587","author":"H Brody","year":"2020","journal-title":"Nature"},{"issue":"1","key":"pone.0321955.ref003","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"B Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"issue":"1","key":"pone.0321955.ref004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.21147\/j.issn.1000-9604.2021.01.09","article-title":"Population-level economic burden of lung cancer in China: Provisional prevalence-based estimations, 2017-2030","volume":"33","author":"C Liu","year":"2021","journal-title":"Chin J Cancer Res"},{"issue":"6","key":"pone.0321955.ref005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.7326\/0003-4819-159-6-201309170-00690","article-title":"Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation","volume":"159","author":"LL Humphrey","year":"2013","journal-title":"Ann Intern Med"},{"issue":"2","key":"pone.0321955.ref006","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/RTI.0b013e3181d29ccf","article-title":"Angiogenesis in non-small cell lung cancer: imaging with perfusion computed tomography","volume":"25","author":"QS Ng","year":"2010","journal-title":"J Thorac Imaging"},{"issue":"4","key":"pone.0321955.ref007","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1634\/theoncologist.2010-0189","article-title":"18F-FDG PET\/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature review","volume":"16","author":"AKH Moller","year":"2011","journal-title":"Oncologist"},{"issue":"4","key":"pone.0321955.ref008","doi-asserted-by":"crossref","first-page":"045006","DOI":"10.1088\/1361-6560\/ab6e51","article-title":"A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics","volume":"65","author":"X Wang","year":"2020","journal-title":"Phys Med Biol"},{"issue":"1","key":"pone.0321955.ref009","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12890-024-02918-w","article-title":"Distribution and characteristics of malignant tumours by lung lobe","volume":"24","author":"Y Nilssen","year":"2024","journal-title":"BMC Pulm Med"},{"key":"pone.0321955.ref010","doi-asserted-by":"crossref","first-page":"e074819","DOI":"10.1136\/bmj-2023-074819","article-title":"Evaluation of clinical prediction models (part 1): from development to external validation","volume":"384","author":"GS Collins","year":"2024","journal-title":"BMJ"},{"key":"pone.0321955.ref011","doi-asserted-by":"crossref","first-page":"e080749","DOI":"10.1136\/bmj-2024-080749","article-title":"Uncertainty of risk estimates from clinical prediction models: rationale, challenges, and approaches","volume":"388","author":"RD Riley","year":"2025","journal-title":"BMJ"},{"issue":"3 Pt 1","key":"pone.0321955.ref012","first-page":"748","article-title":"Association of cigarette smoking and asbestos exposure with location and histology of lung cancer","volume":"157","author":"BW Lee","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0321955.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jss.2013.05.081","article-title":"Severity of emphysema predicts location of lung cancer and 5-y survival of patients with stage I non-small cell lung cancer","volume":"184","author":"M Bishawi","year":"2013","journal-title":"J Surg Res"},{"issue":"2","key":"pone.0321955.ref014","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.lungcan.2014.02.002","article-title":"Invasive adenocarcinoma of the lung is associated with the upper lung regions","volume":"84","author":"CM Kinsey","year":"2014","journal-title":"Lung Cancer"},{"issue":"12","key":"pone.0321955.ref015","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/1759-7714.12869","article-title":"Location of stage I-III non-small cell lung cancer and survival rate: systematic review and meta-analysis","volume":"9","author":"HW Lee","year":"2018","journal-title":"Thorac Cancer"},{"issue":"6","key":"pone.0321955.ref016","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1245\/s10434-018-6401-1","article-title":"Clinical and genetic implications of mutation burden in squamous cell carcinoma of the lung","volume":"25","author":"T Okamoto","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"pone.0321955.ref017","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF00311501","article-title":"Skip metastasis and hidden N2 disease in lung cancer: how successful is mediastinal dissection?","volume":"26","author":"N Tsubota","year":"1996","journal-title":"Surg Today"},{"issue":"2","key":"pone.0321955.ref018","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/CM9.0000000000001802","article-title":"Primary tumor location in lung cancer: the evaluation and administration","volume":"135","author":"X Xie","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"pone.0321955.ref019","first-page":"1271","article-title":"Predilection of lung cancer for the upper lobes: an epidemiologic inquiry","volume":"72","author":"TE Byers","year":"1984","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"pone.0321955.ref020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/carcin\/bgv168","article-title":"EGFR mutation and lobar location of lung adenocarcinoma","volume":"37","author":"C-H Tseng","year":"2016","journal-title":"Carcinogenesis"},{"issue":"4","key":"pone.0321955.ref021","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2214\/AJR.19.21982","article-title":"Imaging features and metastatic patterns of advanced ALK-rearranged non-small cell lung cancer","volume":"214","author":"DP Mendoza","year":"2020","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"pone.0321955.ref022","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1245\/s10434-018-6394-9","article-title":"Incidence and distribution of lobe-specific mediastinal lymph node metastasis in non-small cell lung cancer: data from 4511 resected cases","volume":"25","author":"R-B Liang","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"pone.0321955.ref023","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/1097-0142(197305)31:5<1078::AID-CNCR2820310507>3.0.CO;2-1","article-title":"Carcinoma and diffuse interstitial fibrosis of lung","volume":"31","author":"AE Fraire","year":"1973","journal-title":"Cancer"},{"key":"pone.0321955.ref024","doi-asserted-by":"crossref","first-page":"4784701","DOI":"10.1155\/2020\/4784701","article-title":"Tumor primary location may affect metastasis pattern for patients with stage IV NSCLC: a population-based study","volume":"2020","author":"Q Shan","year":"2020","journal-title":"J Oncol"},{"issue":"1","key":"pone.0321955.ref025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1245\/s10434-021-10504-1","article-title":"A multiple-center nomogram to predict pneumonectomy complication risk for non-small cell lung cancer patients","volume":"29","author":"C Wang","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"pone.0321955.ref026","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1200\/JCO.2014.56.6661","article-title":"Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer","volume":"33","author":"W Liang","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"pone.0321955.ref027","doi-asserted-by":"crossref","first-page":"622","DOI":"10.21037\/tlcr-19-517b","article-title":"A nomogram prognostic model for large cell lung cancer: analysis from the Surveillance, Epidemiology and End Results Database","volume":"10","author":"G Lin","year":"2021","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"pone.0321955.ref028","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ctrv.2009.12.013","article-title":"Is age a negative prognostic factor for the treatment of advanced\/metastatic non-small-cell lung cancer?","volume":"36","author":"AG Pallis","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"pone.0321955.ref029","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3892\/ol.2013.1566","article-title":"Age is a prognostic factor affecting survival in lung cancer patients","volume":"6","author":"F Tas","year":"2013","journal-title":"Oncol Lett"},{"key":"pone.0321955.ref030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2020.07.007","article-title":"Risk-Based lung cancer screening: a systematic review","volume":"147","author":"I Toumazis","year":"2020","journal-title":"Lung Cancer"},{"issue":"1","key":"pone.0321955.ref031","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/prd.12126","article-title":"The aging population: demographics and the biology of aging","volume":"72","author":"E Kanasi","year":"2016","journal-title":"Periodontol 2000"},{"issue":"1","key":"pone.0321955.ref032","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13014-019-1237-9","article-title":"Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous","volume":"14","author":"C Nieder","year":"2019","journal-title":"Radiat Oncol"},{"issue":"12","key":"pone.0321955.ref033","doi-asserted-by":"crossref","first-page":"e0208492","DOI":"10.1371\/journal.pone.0208492","article-title":"Gender as an independent prognostic factor in small-cell lung cancer: Inha Lung Cancer Cohort study using propensity score matching","volume":"13","author":"JH Lim","year":"2018","journal-title":"PLoS One"},{"key":"pone.0321955.ref034","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lungcan.2016.10.010","article-title":"Lung cancer mutation profile of EGFR, ALK, and KRAS: meta-analysis and comparison of never and ever smokers","volume":"102","author":"AM Chapman","year":"2016","journal-title":"Lung Cancer"},{"issue":"1","key":"pone.0321955.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cllc.2023.10.007","article-title":"Lung cancer in women: the past, present, and future","volume":"25","author":"N Florez","year":"2024","journal-title":"Clin Lung Cancer"},{"issue":"10066","key":"pone.0321955.ref036","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"FR Hirsch","year":"2017","journal-title":"Lancet"},{"issue":"10299","key":"pone.0321955.ref037","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","article-title":"Lung cancer","volume":"398","author":"AA Thai","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"pone.0321955.ref038","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"R Rosell","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"pone.0321955.ref039","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"T Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"issue":"27","key":"pone.0321955.ref040","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1200\/JCO.2012.44.2806","article-title":"Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations","volume":"31","author":"LV Sequist","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0321955.ref041","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(12)70489-8","article-title":"Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study","volume":"14","author":"PA J\u00e4nne","year":"2013","journal-title":"Lancet Oncol"},{"issue":"8","key":"pone.0321955.ref042","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/ijms18081713","article-title":"Estrogen, estrogen receptor and lung cancer","volume":"18","author":"L-H Hsu","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"8","key":"pone.0321955.ref043","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jnci\/djz094","article-title":"Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis","volume":"111","author":"F Conforti","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"pone.0321955.ref044","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1158\/1078-0432.CCR-23-1736","article-title":"Estrogen receptor and immune checkpoint inhibitors: new partners in lung cancer?","volume":"29","author":"K Valencia","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"5","key":"pone.0321955.ref045","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/JTO.0b013e31819cce50","article-title":"Lymph node dissection for lung cancer: significance, strategy, and technique","volume":"4","author":"S Watanabe","year":"2009","journal-title":"J Thorac Oncol"},{"issue":"11","key":"pone.0321955.ref046","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1200\/JCO.2016.71.8544","article-title":"Numbers or stations: from systematic sampling to individualized lymph node dissection in non-small-cell lung cancer","volume":"35","author":"W-Z Zhong","year":"2017","journal-title":"J Clin Oncol"},{"issue":"11","key":"pone.0321955.ref047","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1200\/JCO.2016.67.5140","article-title":"Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung cancer: a population study of the US SEER Database and a Chinese Multi-Institutional Registry","volume":"35","author":"W Liang","year":"2017","journal-title":"J Clin Oncol"},{"issue":"4","key":"pone.0321955.ref048","doi-asserted-by":"crossref","first-page":"367","DOI":"10.21037\/tlcr.2019.08.16","article-title":"Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study","volume":"8","author":"X-Q Zheng","year":"2019","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"pone.0321955.ref049","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","article-title":"Metastatic sites and survival in lung cancer","volume":"86","author":"M Riihim\u00e4ki","year":"2014","journal-title":"Lung Cancer"},{"issue":"7","key":"pone.0321955.ref050","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","article-title":"The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for revision of the TNM stage groups in the forthcoming (Ninth) edition of the TNM classification for lung cancer","volume":"19","author":"R Rami-Porta","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"8","key":"pone.0321955.ref051","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","article-title":"Toward personalized treatment approaches for non-small-cell lung cancer","volume":"27","author":"M Wang","year":"2021","journal-title":"Nat Med"},{"issue":"4","key":"pone.0321955.ref052","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, Version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"GJ Riely","year":"2024","journal-title":"J Natl Compr Canc Netw"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T17:40:42Z","timestamp":1745948442000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0321955"}},"subtitle":[],"editor":[{"given":"Filomena","family":"de Nigris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0321955","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}